Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11576
CALL
AC Immune
ACIU
$269M
| $64K | ﹤0.01% |
23,700
-99,700
| -81% | -$312K |
|
11577
Xenetic Biosciences
XBIO
$9.3M
| $63.9K | ﹤0.01% |
+15,859
| New | +$64K |
|
|
NCZ
11578
Virtus Convertible & Income Fund II
NCZ
$298M
| $63.8K | ﹤0.01% |
5,097
-4,571
| -47% | -$58.1K |
|
|
GNT
11579
GAMCO Natural Resources, Gold & Income Trust
GNT
$155M
| $63.8K | ﹤0.01% |
12,053
-17,799
| -60% | -$103K |
|
11580
Elutia
ELUT
$39M
| $63.4K | ﹤0.01% |
+16,949
| New | +$65.7K |
|
|
FLNT
11581
Fluent
FLNT
$117M
| $63.4K | ﹤0.01% |
25,146
-873
| -3% | -$2.54K |
|
|
HSHP
11582
Himalaya Shipping
HSHP
$768M
| $63.2K | ﹤0.01% |
+13,006
| New | +$85.1K |
|
11583
Crown Crafts
CRWS
$31.2M
| $63.2K | ﹤0.01% |
+14,108
| New | +$65.2K |
|
|
DADA
11584
DELISTED
Dada Nexus
DADA
| $63.2K | ﹤0.01% |
52,227
-88,256
| -63% | -$141K |
|
11585
MicroCloud Hologram
HOLO
$43.3M
| $63K | ﹤0.01% |
+320
| New | +$40.4K |
|
|
IHD
11586
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$136M
| $63K | ﹤0.01% |
+12,574
| New | +$66.9K |
|
11587
CALL
Paysign
PAYS
$743M
| $61.9K | ﹤0.01% |
20,500
-121,500
| -86% | -$426K |
|
11588
CALL
Future Fuel
FF
$228M
| $61.9K | ﹤0.01% |
11,700
-260,100
| -96% | -$1.45M |
|
|
OLPX
11589
CALL
DELISTED
Olaplex Holdings
OLPX
| $61.8K | ﹤0.01% |
35,700
-44,900
| -56% | -$89.4K |
|
11590
CytomX Therapeutics
CTMX
$745M
| $61.6K | ﹤0.01% |
59,778
+49,474
| +480% | +$53.2K |
|
|
ACCD
11591
PUT
DELISTED
Accolade Inc
ACCD
| $61.6K | ﹤0.01% |
18,000
-22,600
| -56% | -$80.3K |
|
11592
Bionano Genomics
BNGO
$14.3M
| $61.5K | ﹤0.01% |
3,553
+2,733
| +333% | +$46.7K |
|
11593
Zura Bio
ZURA
$561M
| $61.4K | ﹤0.01% |
24,566
-33,292
| -58% | -$119K |
|
11594
PUT
Good Times Restaurants
GTIM
$15.8M
| $61.1K | ﹤0.01% |
23,600
-17,000
| -42% | -$46.1K |
|
11595
CALL
Savara
SVRA
$1.13B
| $61.1K | ﹤0.01% |
19,900
-7,000
| -26% | -$24.4K |
|
11596
CALL
WidePoint Corp
WYY
$102M
| $61K | ﹤0.01% |
+12,600
| New | +$54.5K |
|
|
NXDR
11597
CALL
Nextdoor Holdings
NXDR
$897M
| $60.7K | ﹤0.01% |
25,600
-33,900
| -57% | -$84.1K |
|
11598
CALL
Genasys
GNSS
$70.6M
| $60.6K | ﹤0.01% |
23,300
-800
| -3% | -$2.81K |
|
11599
The ONE Group
STKS
$52.4M
| $60.3K | ﹤0.01% |
+20,798
| New | +$69.1K |
|
11600
PUT
Telos
TLS
$360M
| $60.2K | ﹤0.01% |
17,600
-7,800
| -31% | -$27.9K |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.